W. Masanta

Emerging Rapid Resistance Testing Methods for Clinical Microbiology Laboratories and Their Potential Impact on Patient Management

H. Frickmann, A. Zautner, W. O. Masanta, 2014, BioMed research international.

Proteome Profiling by Label‐Free Mass Spectrometry Reveals Differentiated Response of Campylobacter jejuni 81–176 to Sublethal Concentrations of Bile Acids

A. Leha, C. Lenz, M. Dakna, 2018, Proteomics. Clinical applications.

Quantitative Proteomics Analysis of Global Protein Expression in Campylobacter jejuni Cultured in Sublethal Concentrations of Bile Acids and Varying Temperatures

W. O. Masanta, W. Masanta, 2017 .

Modification of Intestinal Microbiota and Its Consequences for Innate Immune Response in the Pathogenesis of Campylobacteriosis

M. Heimesaat, S. Bereswill, U. Groß, 2013, Clinical & developmental immunology.

Proteotyping as alternate typing method to differentiate Campylobacter coli clades

T. Riedel, U. Groß, A. Zautner, 2019, Scientific Reports.

Proteome profiling of Campylobacter jejuni 81–176 at 37 °C and 42 °C by label-free mass spectrometry

A. Zautner, W. Bohne, R. Lugert, 2024, BMC microbiology.

Seroprevalence of campylobacteriosis and relevant post-infectious sequelae

R. Schmidt-Ott, U. Groß, A. Zautner, 2014, European Journal of Clinical Microbiology & Infectious Diseases.